Live
Endpoints NewsFlagship startup loses CEO to Ipsen; Ionis to shed nearly six decades of board experienceIlluminaSwiss National Bank Reduces Illumina Holdings - National TodayBioPharma DiveNew FDA guidance could elevate pharma’s biosimilar market10x Genomics Blog3 Healthcare Stocks to Avoid in 2026: Analysis of Underperformers - News and Statistics - IndexBox - Market Intelligence PlatformAgilentMagnetar Financial LLC Decreases Holdings in Agilent Technologies, Inc. $A - MarketBeat10x Genomics Blog3 Healthcare Stocks We’re Skeptical Of - Yahoo! Finance CanadaAgilentPreventive Control Of Sequencing Through The Insert With The Agilent 5200 Fragment Analyzer System - bioprocessonline.comEndpoints NewsGrail names new CEO as Bob Ragusa retiresFierceBiotechStop Asking for an AI strategy: 3 questions clinical leaders should ask insteadThermo FisherInsider Sell: Michael Shafer Sells Shares of Thermo Fisher Scien - GuruFocusCellHuman-specific features of the cerebellum and ZP2-regulated synapse developmentCellCell-type-specific transposon demethylation and TAD remodeling in aging mouse brain
Endpoints News Mar 13, 2026

Flagship startup loses CEO to Ipsen; Ionis to shed nearly six decades of board experience

Flagship startup loses CEO to Ipsen; Ionis to shed nearly six decades of board experience

Original
Body unavailable. Use the original source.

Directory

59 All